Hopp til innhold

Onkologi (pediatri)

Tilpasset/modifisert kjemoterapi (doser tilpasset eller utsatt)

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. (åpner nytt vindu)

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

Kilde‎: N Engl J Med 1998;338(8):499-505.

Arkiv‎: PubMed 9468466

DOI‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 (åpner nytt vindu)

Childhood cancer and the Jehovah's Witness faith. (åpner nytt vindu)

Frankel LS, Damme CJ, Eys JV.

Kilde‎: Pediatrics 1977;60(6):916-21.

Arkiv‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (åpner nytt vindu)

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. (åpner nytt vindu)

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

Kilde‎: J Clin Oncol 2004;22(24):4888-92.

Arkiv‎: PubMed 15611504

DOI‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 (åpner nytt vindu)

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. (åpner nytt vindu)

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

Kilde‎: JAMA Oncol 2022;8(1):79-87. 

Arkiv‎: PubMed 34762093

DOI‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ (åpner nytt vindu)

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. (åpner nytt vindu)

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

Kilde‎: Haematologica 2000;85(11):1221-2.

Arkiv‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 (åpner nytt vindu)

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. (åpner nytt vindu)

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

Kilde‎: Bone Marrow Transplant 2016;51(7):1002-3.

Arkiv‎: PubMed 26950381

DOI‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 (åpner nytt vindu)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (åpner nytt vindu)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Kilde‎: Bone Marrow Transplant 2003;32(4):433-6.

Arkiv‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (åpner nytt vindu)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (åpner nytt vindu)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Kilde‎: Bone Marrow Transplant 2005;36(8):715-20.

Arkiv‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (åpner nytt vindu)

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. (åpner nytt vindu)

Zwaan CM, Kaspers GJ

Kilde‎: Br J Haematol 2004;127(3):264-79.

Arkiv‎: PubMed 15491285

DOI‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 (åpner nytt vindu)